Abstract
Here we present a case of complement-mediated thrombotic microangiopathy (TMA) in a patient who has a background of Stage 5 chronic kidney disease secondary to Alport syndrome. We explain our approach to the diagnosis of TMA, especially the reliance on non-renal manifestations of TMA and the role of kidney biopsy given there was a background of advanced kidney impairment at baseline.
| Original language | English |
|---|---|
| Pages (from-to) | 688-690 |
| Number of pages | 3 |
| Journal | Nephrology |
| Volume | 29 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - 2024 |
Bibliographical note
Publisher Copyright:© 2024 The Authors. Nephrology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Nephrology.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- acute kidney injury
- Alport syndrome (hereditary nephritis)
- thrombotic microangiopathy
Fingerprint
Dive into the research topics of 'Complement-mediated thrombotic microangiopathy on a background of Alport syndrome: a case report'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver